Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
Journal of Medicinal Chemistry|December 13, 2021
Discovery of Novel BRD4 Ligand Scaffolds by Automated Navigation of the Fragment Chemical SpaceSerena G Piticchio, Míriam Martínez-Cartró, Salvatore Scaffidi, et al.Bioorganic & Medicinal Chemistry Letters|February 17, 2006
4-Amino derivatives of the Hsp90 inhibitor CCT018159Xavier Barril, Mandy C Beswick, Adam Collier, et al.Chemmedchem|November 11, 2015
Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth FactorNúria Bayó-Puxan, Ricard Rodríguez-Mias, Michael Goldflam, et al.Plos One|November 29, 2023
Validation of a highly sensitive HaloTag-based assay to evaluate the potency of a novel class of allosteric β-Galactosidase correctorsMikhail Rudinskiy, Maria Pons-Vizcarra, Tatiana Soldà, et al.Chemical Science|June 14, 2021
Fluorogenic Trp(redBODIPY) cyclopeptide targeting keratin 1 for imaging of aggressive carcinomasRamon Subiros-Funosas, Vivian Cheuk Lam Ho, Nicole D Barth, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 20, 2025
Discovering Uncharted Binding Pockets on E3 Ligases Leads to the Identification of FBW7 Allosteric ModulatorsMíriam Martínez-Cartró, Álvaro Serrano-Morrás, Andrea Bertran-Mostazo, et al.Antibiotics (Basel, Switzerland)|May 28, 2022
Computational Design of Inhibitors Targeting the Catalytic β Subunit of <i>Escherichia coli</i> F<sub>O</sub>F<sub>1</sub>-ATP SynthaseLuis Pablo Avila-Barrientos, Luis Fernando Cofas-Vargas, Guillermin Agüero-Chapin, et al.Chemistry & Biology|June 26, 2004
Structure-activity relationships in purine-based inhibitor binding to HSP90 isoformsLisa Wright, Xavier Barril, Brian Dymock, et al.Journal of Medicinal Chemistry|April 21, 2009
Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's diseaseJosé Marco-Contelles, Rafael León, Cristóbal de los Ríos, et al.Journal of Medicinal Chemistry|June 23, 2022
Cosolvent Sites-Based Discovery of <i>Mycobacterium Tuberculosis</i> Protein Kinase G InhibitorsOsvaldo Burastero, Lucas A Defelipe, Gabriel Gola, et al.Pageof 8